Augmedix, Inc. (AUGX)
2.350
0.00 (0.00%)
Inactive · Last trade price
on Oct 1, 2024
Augmedix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 28.22 | 46.22 | 21.25 | 41.26 | 20.76 | 9.6 | Upgrade
|
Cash & Short-Term Investments | 28.22 | 46.22 | 21.25 | 41.26 | 20.76 | 9.6 | Upgrade
|
Cash Growth | 14.94% | 117.48% | -48.49% | 98.70% | 116.20% | -3.14% | Upgrade
|
Receivables | 9.25 | 8.57 | 6.35 | 7.18 | 2.69 | 2.29 | Upgrade
|
Prepaid Expenses | 2.01 | 1.91 | 1.82 | 2 | 1.1 | 0.46 | Upgrade
|
Restricted Cash | - | 0.13 | 0.13 | 0.13 | 2.21 | 2 | Upgrade
|
Other Current Assets | 0.44 | - | - | 0.2 | - | - | Upgrade
|
Total Current Assets | 39.93 | 56.82 | 29.55 | 50.76 | 26.77 | 14.35 | Upgrade
|
Property, Plant & Equipment | 7.76 | 8.96 | 3.14 | 0.98 | 0.99 | 1.21 | Upgrade
|
Other Long-Term Assets | 5.88 | 0.93 | 0.95 | 0.33 | 0.17 | 0.17 | Upgrade
|
Total Assets | 53.67 | 66.71 | 33.64 | 52.07 | 27.94 | 15.74 | Upgrade
|
Accounts Payable | 0.88 | 0.72 | 1.56 | 1.37 | 0.26 | 0.64 | Upgrade
|
Accrued Expenses | 5.44 | 5.3 | 4.45 | 3.44 | 2.53 | 1.79 | Upgrade
|
Current Portion of Long-Term Debt | 5 | 5 | 3.75 | 1.5 | 6.61 | 2.89 | Upgrade
|
Current Portion of Leases | 1.43 | 1.49 | 0.87 | - | - | - | Upgrade
|
Current Unearned Revenue | 8.9 | 8.96 | 7.25 | 6.24 | 5.44 | 5.51 | Upgrade
|
Other Current Liabilities | 2.34 | 2.14 | 1.43 | 1.45 | 1.63 | 2.03 | Upgrade
|
Total Current Liabilities | 24 | 23.62 | 19.31 | 13.99 | 16.47 | 12.86 | Upgrade
|
Long-Term Debt | 15.54 | 15.3 | 11.38 | 13.34 | 8.34 | 9.72 | Upgrade
|
Long-Term Leases | 3.3 | 4.05 | 0.97 | - | - | - | Upgrade
|
Other Long-Term Liabilities | 0.36 | 0.42 | 0.51 | 0.67 | - | 0.02 | Upgrade
|
Total Liabilities | 43.2 | 43.39 | 32.18 | 28 | 24.81 | 22.61 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 171.48 | 169.2 | 127.69 | 125.48 | 87.05 | 3.17 | Upgrade
|
Retained Earnings | -159.91 | -144.96 | -125.79 | -101.34 | -83.88 | -68.27 | Upgrade
|
Comprehensive Income & Other | -1.1 | -0.92 | -0.44 | -0.07 | -0.05 | -0.04 | Upgrade
|
Total Common Equity | 10.47 | 23.32 | 1.47 | 24.07 | 3.12 | -65.14 | Upgrade
|
Shareholders' Equity | 10.47 | 23.32 | 1.47 | 24.07 | 3.12 | -6.87 | Upgrade
|
Total Liabilities & Equity | 53.67 | 66.71 | 33.64 | 52.07 | 27.94 | 15.74 | Upgrade
|
Total Debt | 25.28 | 25.85 | 16.97 | 14.84 | 14.95 | 12.62 | Upgrade
|
Net Cash (Debt) | 2.95 | 20.37 | 4.28 | 26.42 | 5.81 | -3.01 | Upgrade
|
Net Cash Growth | 314.21% | 376.29% | -83.81% | 354.62% | - | - | Upgrade
|
Net Cash Per Share | 0.06 | 0.46 | 0.11 | 0.91 | 0.83 | -3.62 | Upgrade
|
Filing Date Shares Outstanding | 49.24 | 48.74 | 37.52 | 37.39 | 26.86 | 26.8 | Upgrade
|
Total Common Shares Outstanding | 49.08 | 48.61 | 37.44 | 37.39 | 26.86 | 1.98 | Upgrade
|
Working Capital | 15.93 | 33.21 | 10.24 | 36.77 | 10.3 | 1.49 | Upgrade
|
Book Value Per Share | 0.21 | 0.48 | 0.04 | 0.64 | 0.12 | -32.89 | Upgrade
|
Tangible Book Value | 10.47 | 23.32 | 1.47 | 24.07 | 3.12 | -65.14 | Upgrade
|
Tangible Book Value Per Share | 0.21 | 0.48 | 0.04 | 0.64 | 0.12 | -32.89 | Upgrade
|
Machinery | 5.42 | 5.42 | 7.3 | 6.29 | 5.83 | 5.3 | Upgrade
|
Construction In Progress | 0.01 | 0.39 | 0.16 | - | - | - | Upgrade
|
Leasehold Improvements | 0.92 | 0.72 | 0.46 | 0.51 | 2.19 | 2.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.